drug

mitomycin

1 story · latest Aug 5, 2026

Status: FDA approved Feb 2012 · NDA022572, NDA211728, NDA215793
Brands: Jelmyto, Mitosol, Zusduri
Trials: 1 registered trial in coverage

Relationships

Developed by UroGen Pharma Ltd.

Also known as

mitomycin for pyelocalyceal

Timeline

UroGen posts $50.4 million ZUSDURI revenue, cites patent allowance and pipeline progress

Aug 5Quarterly updatemitomycin UGN-104

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.